{"id":2783,"date":"2023-08-15T15:49:27","date_gmt":"2023-08-15T10:49:27","guid":{"rendered":"https:\/\/cemb.edu.pk\/wp\/?page_id=2783"},"modified":"2025-06-02T16:07:50","modified_gmt":"2025-06-02T11:07:50","slug":"fp-dr-bushra-ijaz","status":"publish","type":"page","link":"https:\/\/www.cemb.edu.pk\/?page_id=2783","title":{"rendered":"Dr Bushra Ijaz"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

FACULTY<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t



Dr. Bushra Ijaz<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Associate Professor<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t


Applied and Functional Genomics<\/a><\/span>
e-mail: bijaz@cemb.edu.pk<\/span><\/span><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr. Bushra Ijaz on completion of M.Phil in molecular biology from the Centre of Excellence in Molecular Biology (CEMB) joined as a research officer in 2006. She received the HEC indigenous Ph.D. fellowship in 2010 and completed her Ph.D. degree in 2015. She is now leading the Applied and Functional Genomics group.<\/p>

Dr. Ijaz, research efforts in genomics and therapeutics, especially in the context of infectious diseases like HCV, dengue, and SARS-CoV-2, as well as various types of cancer (liver, breast, and pancreas), are published in the internationally reputed peer-reviewed journals. Dr. Ijaz has secured six research grants from prestigious funding agencies like HEC, PHEC, and HRI-NIH. She has an impact factor of more than 200.<\/p>

Her research is focused on understanding disease pathogenesis and identifying potential therapeutic targets for deadly diseases. Exploring medicinal plants and plant-based compounds for their antiviral and anticancer properties is a promising avenue of study. Nature has provided us with a rich source of bioactive compounds that have the potential to contribute significantly to the development of new treatments. By delving into the molecular mechanisms underlying these diseases and investigating how specific plant-based compounds interact with them, can potentially uncover novel therapeutic strategies. This could involve elucidating the pathways by which these compounds exert their effects, their modes of action, and their potential for targeting specific disease-related molecules or processes.<\/p>

Dr. Ijaz has filed three patents for compounds identified against HCV and liver fibrosis, translating her research findings into practical solutions for these health challenges. Additionally, she has national and international collaborations with experts in pharmacology, chemistry, nanotechnology and clinical research to help bridge the gap between basic science and translational medicine, ultimately leading to the development of effective treatments for these fatal diseases.<\/p>

Research Interests:<\/strong><\/p>